630 related articles for article (PubMed ID: 15014886)
1. Prion protein conversion in vitro.
Supattapone S
J Mol Med (Berl); 2004 Jun; 82(6):348-56. PubMed ID: 15014886
[TBL] [Abstract][Full Text] [Related]
2. In vitro amplification of protease-resistant prion protein requires free sulfhydryl groups.
Lucassen R; Nishina K; Supattapone S
Biochemistry; 2003 Apr; 42(14):4127-35. PubMed ID: 12680767
[TBL] [Abstract][Full Text] [Related]
3. In vitro prion protein conversion in detergent-solubilized membranes.
Nishina K; Deleault NR; Lucassen RW; Supattapone S
Biochemistry; 2004 Mar; 43(9):2613-21. PubMed ID: 14992599
[TBL] [Abstract][Full Text] [Related]
4. Autocatalytic self-propagation of misfolded prion protein.
Bieschke J; Weber P; Sarafoff N; Beekes M; Giese A; Kretzschmar H
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12207-11. PubMed ID: 15297610
[TBL] [Abstract][Full Text] [Related]
5. In vitro amplification of scrapie and chronic wasting disease PrP(res) using baculovirus-expressed recombinant PrP as substrate.
Faburay B; Tark D; Kanthasamy AG; Richt JA
Prion; 2014; 8(6):393-403. PubMed ID: 25495764
[TBL] [Abstract][Full Text] [Related]
6. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
7. RNA molecules stimulate prion protein conversion.
Deleault NR; Lucassen RW; Supattapone S
Nature; 2003 Oct; 425(6959):717-20. PubMed ID: 14562104
[TBL] [Abstract][Full Text] [Related]
8. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
Piening N; Weber P; Giese A; Kretzschmar H
Biochem Biophys Res Commun; 2005 Jan; 326(2):339-43. PubMed ID: 15582583
[TBL] [Abstract][Full Text] [Related]
9. Copper (II) ions potently inhibit purified PrPres amplification.
Orem NR; Geoghegan JC; Deleault NR; Kascsak R; Supattapone S
J Neurochem; 2006 Mar; 96(5):1409-15. PubMed ID: 16417569
[TBL] [Abstract][Full Text] [Related]
10. Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein.
Kellershohn N; Laurent M
Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):539-45. PubMed ID: 9729459
[TBL] [Abstract][Full Text] [Related]
11. The role of rafts in the fibrillization and aggregation of prions.
Pinheiro TJ
Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
[TBL] [Abstract][Full Text] [Related]
12. Recombinant prion protein refolded with lipid and RNA has the biochemical hallmarks of a prion but lacks in vivo infectivity.
Timmes AG; Moore RA; Fischer ER; Priola SA
PLoS One; 2013; 8(7):e71081. PubMed ID: 23936256
[TBL] [Abstract][Full Text] [Related]
13. In vitro generation of infectious scrapie prions.
Castilla J; Saá P; Hetz C; Soto C
Cell; 2005 Apr; 121(2):195-206. PubMed ID: 15851027
[TBL] [Abstract][Full Text] [Related]
14. The stoichiometry of host PrPC glycoforms modulates the efficiency of PrPSc formation in vitro.
Nishina KA; Deleault NR; Mahal SP; Baskakov I; Luhrs T; Riek R; Supattapone S
Biochemistry; 2006 Nov; 45(47):14129-39. PubMed ID: 17115708
[TBL] [Abstract][Full Text] [Related]
15. Effect of transition metals (Mn, Cu, Fe) and deoxycholic acid (DA) on the conversion of PrPC to PrPres.
Kim NH; Choi JK; Jeong BH; Kim JI; Kwon MS; Carp RI; Kim YS
FASEB J; 2005 May; 19(7):783-5. PubMed ID: 15758042
[TBL] [Abstract][Full Text] [Related]
16. Prion protein aggregation and fibrillogenesis in vitro.
Stöhr J
Subcell Biochem; 2012; 65():91-108. PubMed ID: 23225001
[TBL] [Abstract][Full Text] [Related]
17. The role of glycophosphatidylinositol anchor in the amplification of the scrapie isoform of prion protein in vitro.
Kim JI; Surewicz K; Gambetti P; Surewicz WK
FEBS Lett; 2009 Nov; 583(22):3671-5. PubMed ID: 19854187
[TBL] [Abstract][Full Text] [Related]
18. Formation of native prions from minimal components in vitro.
Deleault NR; Harris BT; Rees JR; Supattapone S
Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9741-6. PubMed ID: 17535913
[TBL] [Abstract][Full Text] [Related]
19. Cofactor and glycosylation preferences for in vitro prion conversion are predominantly determined by strain conformation.
Burke CM; Walsh DJ; Mark KMK; Deleault NR; Nishina KA; Agrimi U; Di Bari MA; Supattapone S
PLoS Pathog; 2020 Apr; 16(4):e1008495. PubMed ID: 32294141
[TBL] [Abstract][Full Text] [Related]
20. Protease-resistant prion protein amplification reconstituted with partially purified substrates and synthetic polyanions.
Deleault NR; Geoghegan JC; Nishina K; Kascsak R; Williamson RA; Supattapone S
J Biol Chem; 2005 Jul; 280(29):26873-9. PubMed ID: 15917229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
